Diet-Induced Obesity Enhances Progression of Hepatocellular Carcinoma through Tenascin-C/Toll-Like Receptor 4 Signaling
Open accessThe DOI matches its Crossref record; 10 of the 10 references it cites were found in a registry or an index.
Abstract
Obesity is an independent risk factor for the development of liver fibrosis/cirrhosis and hepatocellular carcinoma (HCC). Tenascin-C (TnC), an extracellular matrix protein, is transiently expressed during tissue injury and plays a role in fibrogenesis and tumorigenesis. However, the mechanistic role of TnC signaling in the development of HCC remains unknown. We developed a diet-induced obesity HCC mouse model and examined TnC expression and liver injury. To determine the cellular mechanism of TnC signaling in promoting inflammation and hepatocyte epithelial-mesenchymal transition and migration, we used primary hepatocytes and hepatoma and macrophage cell lines. Further, to determine whether elevated TnC expression correlated with obesity-associated HCC, we measured plasma TnC in obese patients with various levels of liver injury. Increased tissue inflammation accompanied with elevated hepatic stellate cell-derived TnC and Toll-like receptor 4 expression was observed in the diet-induced obesity HCC animal model. In vitro studies found enhanced Toll-like receptor 4 signaling activated by TnC, promoting an increased inflammatory response, hepatocyte transformation, and migration. Further, obese patients with cirrhosis alone and in combination with HCC showed significant increases in plasma TnC compared with healthy volunteers and patients with less severe liver injury. Overall, these studies suggest TnC/Toll-like receptor 4 signaling as an important regulator in HCC; inhibiting this signaling axis may be a viable therapeutic target for impeding HCC.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Obesity-induced gut microbial metabolite promotes liver cancer through senescence secretome
Yoshimoto, S., Loo, T. M., Atarashi, K., Kanda, H., Sato, S., Oyadomari, S., Iwakura, Y., Oshima, K., Morita, H., Hattori, M., et al. (2013) · Nature · doi:10.1038/nature12347 · Cited by 2,219
Park, E. J., Lee, J. H., Yu, G.-Y., He, G., Ali, S. R., Holzer, R. G., Österreicher, C. H., Takahashi, H., & Karin, M. (2010) · Cell · doi:10.1016/j.cell.2009.12.052 · Cited by 1,764 · cited 14×
“Overall, these studies suggest TnC/Toll-like receptor 4 signaling as an important regulator in HCC; inhibiting this signaling axis may be a viable therapeutic target for impeding HCC. (Am J Pathol 2016, 186: 145e158; http://dx.doi.org/10.1016/j.ajpath.2015.09.015) Supported by a grant from Carolinas HealthCare System…”
BackgroundInfluentialPromotion of Hepatocellular Carcinoma by the Intestinal Microbiota and TLR4
Dapito, D. H., Mencin, A., Gwak, G.-Y., Pradere, J.-P., Jang, M.-K., Mederacke, I., Caviglia, J. M., Khiabanian, H., Adeyemi, A., Bataller, R., et al. (2012) · Cancer Cell · doi:10.1016/j.ccr.2012.02.007 · Cited by 1,346
Ascha, M. S., Hanouneh, I. A., Lopez, R., Tamimi, T. A.-R., Feldstein, A. F., & Zein, N. N. (2010) · Hepatology · doi:10.1002/hep.23527 · Cited by 1,296
White, D. L., Kanwal, F., & El–Serag, H. B. (2012) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2012.10.001 · Cited by 766
Yu, L.-X., Yan, H.-X., Liu, Q., Yang, W., Wu, H.-P., Dong, W., Tang, L., Lin, Y., He, Y.-Q., Zou, S.-S., et al. (2010) · Hepatology · doi:10.1002/hep.23845 · Cited by 349
Schnabl, B., Purbeck, C. A., Choi, Y. H., Hagedorn, C. H., & Brenner, D. (2003) · Hepatology · doi:10.1053/jhep.2003.50097 · Cited by 224 · cited 1×
“A population of HSCs was characterized by an inflammatory but not a fibrogenic phenotype and may contribute to NASH-associated HCC in noncirrhotic livers.(63) Although NAFLD cirrhotic patients with HCC had lower BMIs than their noncirrhotic counterparts, it is not”
BackgroundJing, Y.-Y., Han, Z.-P., Sun, K., Zhang, S.-S., Hou, J., Liu, Y., Li, R., Gao, L., Zhao, X., Zhao, Q.-D., et al. (2012) · BMC Medicine · doi:10.1186/1741-7015-10-98 · Cited by 162 · cited 1×
“Previous studies found that silencing TLR4 inhibits invasion, survival, and tumorigenicity of prostate cancer cells, whereas LPS enhanced the invasive potential and EMT of HCC cells with elevated TLR4 expression.(46) EMT enhances cell migration and invasion, and increased vimentin expression may play an important role…”
BackgroundZhao, W., Zhang, L., Yin, Z., Su, W., Ren, G., Zhou, C., You, J., Fan, J., & Wang, X. (2011) · International Journal of Cancer · doi:10.1002/ijc.25920 · Cited by 115
Zhao, W., Zhang, L., Xu, Y., Zhang, Z., Ren, G., Tang, K., Kuang, P., Zhao, B., Yin, Z., & Wang, X. (2014) · Laboratory Investigation · doi:10.1038/labinvest.2013.139 · Cited by 111
Cited by
Inflammation and Liver Cancer: Molecular Mechanisms and Therapeutic Targets
Yang, Y., Kim, S., & Seki, E. (2019) · Seminars in Liver Disease · doi:10.1055/s-0038-1676806 · Cited by 449
Lonardo, A., Mantovani, A., Lugari, S., & Targher, G. (2020) · Annals of Hepatology · doi:10.1016/j.aohep.2020.03.001 · Cited by 150
Immunomodulatory Role of the Extracellular Matrix Within the Liver Disease Microenvironment
McQuitty, C. E., Williams, R., Chokshi, S., & Urbani, L. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.574276 · Cited by 146
TNC‑targeted CAR‑macrophage therapy alleviates liver fibrosis in mice
Chen, K., Lin, Z., Chen, L., Zhou, Y., Zhang, W., Wan, H., Huo, Y., Fu, Q., Gao, Z., Cheng, H., et al. (2025) · Military Medical Research · doi:10.1186/s40779-025-00667-3 · Cited by 11
“TNC is highly expressed in various liver diseases, including chronic hepatitis, liver fibrosis, hepatic ischemia/reperfusion injury, and hepatocellular carcinoma [19, 47–49].”
Metadata
- Authors
- Benbow, J. H., Thompson, K. J., Cope, H. L., Brandon-Warner, E., Culberson, C. R., Bossi, K. L., Li, T., Russo, M. W., Gersin, K. S., McKillop, I. H., deLemos, A. S., & Schrum, L. W.
- Venue
- The American Journal of Pathology
- Publisher
- Elsevier BV
- Published
- 2016-01
- Volume
- 186
- Issue
- 1
- Pages
- 145-158
- ISSN
- 0002-9440 (ISSN-L)
- OpenAlex
- W2177007785
- Cited by
- 35
- References
- 10
- FWCI
- 1.19
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Diet-Induced Obesity Enhances Progression of Hepatocellular Carcinoma through Tenascin-C/Toll-Like Receptor 4 Signaling. https://app.cochat.ai/papers/10.1016/j.ajpath.2015.09.015
- The paper
- Benbow, J. H., Thompson, K. J., Cope, H. L., Brandon-Warner, E., Culberson, C. R., Bossi, K. L., Li, T., Russo, M. W., Gersin, K. S., McKillop, I. H., deLemos, A. S., & Schrum, L. W. (2016). Diet-Induced Obesity Enhances Progression of Hepatocellular Carcinoma through Tenascin-C/Toll-Like Receptor 4 Signaling. The American Journal of Pathology. https://doi.org/10.1016/j.ajpath.2015.09.015
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.